Juniper Pharmaceuticals announces strategic reprioritization
Juniper Pharmaceuticals announced a corporate reprioritization to allow the Company to focus its resources on the core businesses of Crinone® progesterone gel and Juniper Pharma Services. These actions are expected to result in cost savings and a cash flow neutral position for 2018. September 18, 2017